Vicor (VICR) VP Davies sells 5,419 shares, exercises options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Vicor Corp VP Philip D. Davies reported option exercises and share sales. On March 5, 2026, he exercised several non-qualified stock options, acquiring common shares at exercise prices including $41.6100, $60.6100, and $75.4300 per share.
That same day, he sold 5,419 shares of Vicor common stock in multiple open-market transactions under a Rule 10b5-1 trading plan adopted on November 21, 2025, at weighted average prices ranging from $177.1800 to $202.2600. Following these transactions, he directly owned 1,920 shares of common stock and held option positions including 15,358, 7,752, and 1,827 option shares in separate grants.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 5,419 shares ($1,027,829)
Net Sell
19 txns
Insider
Davies Philip D
Role
VP Global Sales & Marketing
Sold
5,419 shs ($1.03M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non Qualified Stock Option | 1,920 | $0.00 | -- |
| Exercise | Non Qualified Stock Option | 2,585 | $0.00 | -- |
| Exercise | Non Qualified Stock Option | 914 | $0.00 | -- |
| Exercise | Common Stock | 1,920 | $41.61 | $80K |
| Exercise | Common Stock | 2,585 | $60.61 | $157K |
| Exercise | Common Stock | 914 | $75.43 | $69K |
| Sale | Common Stock | 100 | $177.18 | $18K |
| Sale | Common Stock | 700 | $179.3814 | $126K |
| Sale | Common Stock | 607 | $180.2373 | $109K |
| Sale | Common Stock | 698 | $181.4881 | $127K |
| Sale | Common Stock | 100 | $182.17 | $18K |
| Sale | Common Stock | 100 | $185.51 | $19K |
| Sale | Common Stock | 300 | $187.2567 | $56K |
| Sale | Common Stock | 300 | $189.2067 | $57K |
| Sale | Common Stock | 300 | $193.12 | $58K |
| Sale | Common Stock | 300 | $194.98 | $58K |
| Sale | Common Stock | 100 | $196.45 | $20K |
| Sale | Common Stock | 1,514 | $199.4874 | $302K |
| Sale | Common Stock | 300 | $202.1833 | $61K |
Holdings After Transaction:
Non Qualified Stock Option — 15,358 shares (Direct);
Common Stock — 3,840 shares (Direct)
Footnotes (1)
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.1800 to $177.1800. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.7900 to $179.7700. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $180.0500 to $181.0100. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $181.1600 to $181.9400. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $182.1700 to $182.1700. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.5100 to $185.5100. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.9200 to $187.8800. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.0600 to $189.4800. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.9800 to $193.1900 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.9500 to $195.0000. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $196.4500 to $196.4500. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.4200 to $199.7200. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.1100 to $202.2600 Options expire 2 years from each date of vesting.
FAQ
What insider transactions did Vicor (VICR) executive Philip D. Davies report?
Philip D. Davies reported exercising non-qualified stock options and selling Vicor common shares. On March 5, 2026, he converted several option grants into stock, then executed multiple open-market sales the same day under a pre-established Rule 10b5-1 trading plan.
What is notable about the prices for Philip D. Davies’ Vicor (VICR) stock sales?
The reported sale prices are weighted averages from multiple trades. According to the footnotes, transactions occurred at prices ranging from $177.1800 up to $202.2600 per share, with separate ranges disclosed for each sale block in the Form 4.
What types of securities did Philip D. Davies exercise in this Vicor (VICR) filing?
He exercised non-qualified stock options into Vicor common stock. The filing lists several option grants, with exercises at prices including $41.6100, $60.6100, and $75.4300 per share, and notes that these options generally expire two years from each vesting date.